
Wolfgang studied Biochemistry in Düsseldorf and spent his postdoc at Columbia University in molecular oncology. He then worked for about 20 years in pharma and biotech companies in Germany, the UK and Italy, developing new therapies for cancer, inflammatory and neurodegenerative diseases. Wolfgang returned to academia in 2015 to work for the VIB in Leuven. In 2018 he became director of the European research infrastructure EU-OPENSCREEN ERIC in Berlin before joining ECL in June 2025.
Updated: September 2026